Swiss drugs regulator approves first bivalent Covid-19 booster

BERLIN, Aug 29 (Reuters) – Swiss drugs regulator Swissmedic said on Monday that it has approved the first bivalent Covid-19 booster vaccine in the country.

Moderna’s Spikevax vaccine, which contains mRNA against two coronavirus variants, is authorized for anyone 18 years or older, said Swissmedic.

Our Standards: The Thomson Reuters Trust Principles.